Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2025

Aug 2, 2025

30587_dirs_2025-08-01_ce1218cd-79e5-4182-9246-070c67c1303c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-07-30

Reporting Person: Venker Eric (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-30 Common Shares A 198413 Acquired 1660636 Direct

Footnotes

F1: Reflects an award of restricted stock units with respect to Common Shares ("RSUs"), with a vesting commencement date of May 20, 2025, which service-vest (i) 25% on the first anniversary of the vesting commencement date and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through each vesting date.